Pharmacokinetic Bioequivalence Crossover Study of Branded Generic and Innovator Formulations of the Cholesterol Lowering Agent Ezetimibe

被引：6
|
作者：
Palmer, Jonathan L. [1 ]
Kunhihitlu, Anil [2 ]
Costantini, Andrea [3 ]
Esquivel, Florencia [3 ]
Roush, John [4 ]
Edwards, Karina [5 ]
Hill, Thomas W. K. [6 ]
机构：
[1] GlaxoSmithKline, Uxbridge UB11 1BT, Middx, England
[2] Clinigene Int Ltd, Bangalore, Karnataka, India
[3] Labs Phoenix SAICF, Malvinas Argentinas, Provincia Bueno, Argentina
[4] GlaxoSmithKline, Res Triangle Pk, NC USA
[5] GlaxoSmithKline, Harlow, Essex, England
[6] Biopharma Consulting Ltd, Colwyn Bay, Wales
来源：
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT | 2014年 / 3卷 / 03期
关键词：
bioequivalence; ezetimibe; branded generic; innovator; NPC1L1;
D O I：
10.1002/cpdd.80
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页码：242 / 248
页数：7
相关论文
共 50 条
  • [1] Lack of pharmacokinetic bioequivalence between generic and branded amoxicillin formulations. A post-marketing clinical study on healthy volunteers
    Del Tacca, Mario
    Pasqualetti, Giuseppe
    Di Paolo, Antonello
    Virdis, Agostino
    Massimetti, Gabriele
    Gori, Giovanni
    Versari, Daniele
    Taddei, Stefano
    Blandizzi, Corrado
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 68 (01) : 34 - 42
  • [2] Bioequivalence of abacavir generic and innovator formulations under fasting and fed conditions
    Marier, J. F.
    Borges, M.
    Plante, G.
    DiMarco, M.
    Morelli, G.
    Tippabhotla, S. K.
    Vijan, T.
    Singla, A. K.
    Garg, M.
    Monif, T.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2006, 44 (06) : 284 - 291
  • [3] Sampling times and genotyping concerns in bioequivalence evaluation of branded and generic formulations
    Zhao, Xiao-Ying
    Xu, Hui-Min
    Zhou, Quan
    [J]. THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2013, 9 : 463 - 466
  • [4] Pharmacokinetic and bioequivalence evaluation of two generic formulations of oral artesunate
    K. Na-Bangchang
    J. Karbwang
    K. Congpoung
    A. Thanavibul
    R. Ubalee
    [J]. European Journal of Clinical Pharmacology, 1998, 53 : 375 - 376
  • [5] Pharmacokinetic and bioequivalence evaluation of two generic formulations of oral artesunate
    Na-Bangchang, K
    Karbwang, J
    Congpoung, K
    Thanavibul, A
    Ubalee, R
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 53 (05) : 375 - 376
  • [6] Bioequivalence and Safety of Generic Glecaprevir/Pibrentasvir Compared to a Branded Product: A Randomized, Crossover Study in Healthy Volunteers
    Noskov, Sergei
    Parulya, Olesya
    Lutskova, Lyudmila
    Arefeva, Anna
    Protsenko, Ekaterina
    Banko, Veniamin
    Radaeva, Kseniia
    Matvienko, Iuliia
    Gefen, Maria
    Karnakova, Polina
    Knyazeva, Alina
    Komarov, Timofey
    Archakova, Olga
    Shohin, Igor
    [J]. CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2024,
  • [7] Sampling times and genotyping concerns in bioequivalence evaluation of branded and generic formulations Authors' reply
    Del Tacca, Mario
    Pasqualetti, Giuseppe
    Gori, Giovanni
    Pepe, Pasquale
    Di Paolo, Antonello
    Lastella, Marianna
    De Negri, Ferdinando
    Blandizzi, Corrado
    [J]. THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2013, 9 : 467 - 468
  • [8] Generic lamotrigine extended-release tablets are bioequivalent to innovator drug in fully replicated crossover bioequivalence study
    Fang, Lanyan
    Li, Zhichuan
    Kinjo, Minori
    Lomonaco, Sara
    Zheng, Nan
    Jiang, Wenlei
    Zhao, Liang
    [J]. EPILEPSIA, 2023, 64 (01) : 152 - 161
  • [9] Pharmacokinetic and Bioequivalence Studies of a Newly Developed Branded Generic of Candesartan Cilexetil Tablets in Healthy Volunteers
    Patel, Rajesh
    Palmer, Jonathan L.
    Joshi, Shashidhar
    Di Cio Gimena, Alejandro
    Esquivel, Florencia
    [J]. CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2017, 6 (05): : 492 - 498
  • [10] Comparative pharmacokinetic and pharmacodynamic evaluation of branded and generic formulations of meloxicam in healthy male volunteers
    Del Tacca, Mario
    Pasqualetti, Giuseppe
    Gori, Giovanni
    Pepe, Pasquale
    Di Paolo, Antonello
    Lastella, Marianna
    De Negri, Ferdinando
    Blandizzi, Corrado
    [J]. THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2013, 9 : 303 - 311
12345